What to Know About the New Nasal Spray for Tough Depression …
4 days ago · A study by Johnson & Johnson, the company that makes Spravato, showed that 22.5% of people using esketamine nasal spray achieved remission from major depression in …
FDA approves 'ketamine' nasal spray for depression - Live Science
18 hours ago · A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what …
Spravato Nasal Spray Can Now Be Used Alone for Treatment …
3 days ago · The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment …
FDA-Approved Nasal Spray For Depression Is First Of Its Kind
Jan 24, 2025 · A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & …
FDA approves Johnson & Johnson nasal spray Spravato for depression
Jan 21, 2025 · Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.
FDA approves first-of-its-kind nasal spray for severe depression
Jan 22, 2025 · Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive …
SPRAVATO® (esketamine): A Prescription Nasal Spray
SPRAVATO®, the only FDA-approved nasal spray for adults with treatment-resistant depression, reduces depression symptoms when two or more oral antidepressants haven't worked. …
Spravato Nasal Spray: Uses, Dosage, Side Effects - Drugs.com
Aug 23, 2023 · Spravato (esketamine) nasal spray is used for treatment-resistant depression and major depressive disorder (MDD) with acute suicidal ideation or behavior. Includes Spravato …
FDA approves new nasal spray medication for treatment-resistant ...
The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried...
Esketamine for Treatment-Resistant Depression - Johns Hopkins Medicine
But it wasn’t until recently that esketamine, a more potent version of ketamine, earned FDA approval specifically for use as a nasal spray for those with treatment-resistant depression. …